Module

Current Issues in the Development and Clinical Role of Novel Agents for Chronic Hepatitis C

Source: The Future of HCV: Small Molecules in Development for Chronic Hepatitis C

Current Issues in the Development and Clinical Role of Novel Agents for Chronic Hepatitis C


Program Director: Raymond T. Chung, MD

Faculty:

  • Raymond T. Chung, MD

CME CREDIT INFORMATION

Release Date: 08/27/07

Expiration Date: 08/26/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • List considerations related to future clinical trial design for small-molecule agents
  • Describe the continued role of standard of care agents with small-molecule targeted agents
  • Discuss the potential timing for the use of novel agents in hepatitis C virus–infected patients in different patient types

Topics covered include:

  • Introduction
  • Challenges to the Introduction of STAT-C Agents Into Clinical Trials for HCV
  • Construction of a Successful Multidrug HCV Combination Regimen
  • HCV Treatment Scenarios
    • Treatment-Naive Patients
    • The Peginterferon alfa and Ribavirin Nonresponder or Relapser 
    • Renal Insufficiency or Interferon Intolerance
    • HCV/HIV Coinfection
    • Advanced Liver Disease and Transplantation
    • Postexposure Prophylaxis
  • Possible Clinical Trials During the Next 10 Years
  • What Will Be Realistic Endpoints in the Era of STAT-C Agents?
  • Summary
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.